CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
This Quarter Return
+22.53%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$295M
AUM Growth
+$295M
(+19%)
Cap. Flow
+$10.2M
Cap. Flow
% of AUM
3.44%
Top 10 Holdings %
Top 10 Hldgs %
32.39%
Holding
456
New
65
Increased
317
Reduced
38
Closed
9
Top Buys
| 1 |
NVIDIA
NVDA
|
$7.81M |
| 2 |
PayPal
PYPL
|
$4.77M |
| 3 |
STAAR Surgical
STAA
|
$3.64M |
| 4 |
Chipotle Mexican Grill
CMG
|
$3.46M |
| 5 |
Microsoft
MSFT
|
$3.33M |
Top Sells
| 1 |
iQIYI
IQ
|
$7.64M |
| 2 |
Pinduoduo
PDD
|
$6.59M |
| 3 |
ON Semiconductor
ON
|
$4.45M |
| 4 |
Apple
AAPL
|
$3.07M |
| 5 |
Rambus
RMBS
|
$2.77M |
Sector Composition
| 1 | Technology | 38.43% |
| 2 | Consumer Discretionary | 23.55% |
| 3 | Healthcare | 18.31% |
| 4 | Communication Services | 8.83% |
| 5 | Financials | 4.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Schrodinger
SDGR
$1.41B
| $9.22K | ﹤0.01% |
350
| – | – |
|
302
Arcutis Biotherapeutics
ARQT
$1.84B
| $9.11K | ﹤0.01% |
828
+209
| +34% | +$2.3K |
|
303
Anavex Life Sciences
AVXL
$814M
| $9.06K | ﹤0.01% |
1,057
+265
| +33% | +$2.27K |
|
|
WBA
304
DELISTED
Walgreens Boots Alliance
WBA
| $9.03K | ﹤0.01% |
+261
| New | +$9.03K |
|
305
Verisk Analytics
VRSK
$37B
| $9.02K | ﹤0.01% |
+47
| New | +$9.02K |
|
306
IDEAYA Biosciences
IDYA
$2.23B
| $8.95K | ﹤0.01% |
652
+163
| +33% | +$2.24K |
|
|
ME
307
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $8.92K | ﹤0.01% |
3,912
+999
| +34% | +$2.28K |
|
308
Baker Hughes
BKR
$44.7B
| $8.83K | ﹤0.01% |
+306
| New | +$8.83K |
|
309
Exact Sciences
EXAS
$9.09B
| $8.68K | ﹤0.01% |
128
| – | – |
|
|
ANSS
310
DELISTED
Ansys
ANSS
| $8.65K | ﹤0.01% |
+26
| New | +$8.65K |
|
311
Arcturus Therapeutics
ARCT
$453M
| $8.63K | ﹤0.01% |
360
+91
| +34% | +$2.18K |
|
312
Enphase Energy
ENPH
$4.84B
| $8.62K | ﹤0.01% |
+41
| New | +$8.62K |
|
313
Harrow
HROW
$1.4B
| $8.53K | ﹤0.01% |
403
+125
| +45% | +$2.65K |
|
314
CoStar Group
CSGP
$37.3B
| $8.47K | ﹤0.01% |
+123
| New | +$8.47K |
|
315
Sana Biotechnology
SANA
$721M
| $8.45K | ﹤0.01% |
2,584
+646
| +33% | +$2.11K |
|
316
RAPT Therapeutics
RAPT
$196M
| $8.44K | ﹤0.01% |
460
+115
| +33% | +$2.11K |
|
317
AnaptysBio
ANAB
$577M
| $8.38K | ﹤0.01% |
385
+96
| +33% | +$2.09K |
|
318
ARS Pharmaceuticals
SPRY
$1.1B
| $8.27K | ﹤0.01% |
1,270
+317
| +33% | +$2.06K |
|
319
Castle Biosciences
CSTL
$702M
| $8.18K | ﹤0.01% |
360
+92
| +34% | +$2.09K |
|
320
Dyne Therapeutics
DYN
$1.92B
| $8.13K | ﹤0.01% |
706
+176
| +33% | +$2.03K |
|
321
Novavax
NVAX
$1.23B
| $8.09K | ﹤0.01% |
1,167
+313
| +37% | +$2.17K |
|
322
Lyell Immunopharma
LYEL
$219M
| $7.98K | ﹤0.01% |
3,382
+849
| +34% | +$2K |
|
323
Terns Pharmaceuticals
TERN
$662M
| $7.95K | ﹤0.01% |
671
+288
| +75% | +$3.41K |
|
|
AVDL
324
Avadel Pharmaceuticals
AVDL
$1.45B
| $7.8K | ﹤0.01% |
851
+233
| +38% | +$2.13K |
|
325
Constellation Energy
CEG
$96B
| $7.77K | ﹤0.01% |
+99
| New | +$7.77K |
|